Diagnos Laboratorium Utama Tbk. vs Wismilak Inti Makmur Tbk. — how do they compare? Diagnos Laboratorium Utama Tbk. trades at Rp224 (market cap 310.75B, 963.6K 24h volume), while Wismilak Inti Makmur Tbk. trades at Rp1,580 (market cap 3.33T, 381.5K 24h volume). The key difference: Wismilak Inti Makmur Tbk. is far larger — about 10.7× Diagnos Laboratorium Utama Tbk.'s market cap, and Diagnos Laboratorium Utama Tbk. is more actively traded (963.6K versus 381.5K). Which is the better fit depends on your goals.
| DGNS | WIIM | |
|---|---|---|
Market Cap | 310.75B | 3.33T |
Volume | 963.6K | 381.5K |
Lot | 9.64K | 3.82K |
Turnover | 217.67M | 603.29M |
Average Price | 225.89 | 1,581.36 |
Value | 217.67M | 603.29M |
Indicative Equilibrium Price | 226 | 1,580 |
Indicative Equilibrium Volume | 1K | 21 |
Trailing returns across standard periods
Latest headlines on both assets
PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Read more on DGNS →PT Wismilak Inti Makmur Tbk (the Company) was established based on Notarial Deed No. 22 of Bagio Atmadja, S.H., dated December 14, 1994.
Read more on WIIM →